Trials / Conditions / Stage IIIA Esophageal Cancer
Stage IIIA Esophageal Cancer
5 registered clinical trials studyying Stage IIIA Esophageal Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer NCT03154190 | Stanford University | N/A |
| Withdrawn | C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced NCT02344810 | Eastern Cooperative Oncology Group | Phase 1 / Phase 2 |
| Unknown | FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients Wit NCT02037048 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors NCT01522820 | Roswell Park Cancer Institute | Phase 1 |
| Completed | Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal NCT01212822 | Fox Chase Cancer Center | Phase 2 |